XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Earnings Per Share | 9 Months Ended
--- | ---
Mar. 31, 2018
Earnings Per Share [Abstract] |
Earnings Per Share | Note 3. Earnings Per Share The following table sets forth the computation of basic and diluted net (loss) income per share (in millions, except per share data):
| Three Months Ended |  | Nine Months Ended
| March 31, 2018 |  | April 1, 2017 |  | March 31, 2018 |  | April 1, 2017
Numerator: |  |  |  |  |  |  |  |  |
Net (loss) income | $ | (8.7 | ) |  | $ | 26.0 |  |  | $ | (17.2 | ) |  | $ | 153.2 |
Denominator: |  |  |  |  |  |  |
Weighted-average number of common shares outstanding |  |  |  |  |  |  |
Basic | 226.3 |  |  | 229.4 |  |  | 227.3 |  |  | 230.8 |
Effect of dilutive securities from stock-based benefit plans | — |  |  | 5.2 |  |  | — |  |  | 5.1 |
Diluted | 226.3 |  |  | 234.6 |  |  | 227.3 |  |  | 235.9 |
Net (loss) income per share: |  |  |  |  |  |  |
Basic | $ | (0.04 | ) |  | $ | 0.11 |  |  | $ | (0.08 | ) |  | $ | 0.66 |
Diluted | $ | (0.04 | ) |  | $ | 0.11 |  |  | $ | (0.08 | ) |  | $ | 0.65 |
The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net (loss) income per share because their effect would have been anti-dilutive (in millions):
| Three Months Ended |  | Nine Months Ended
| March 31, 2018 (1) (2) |  | April 1, 2017 (1) (2) |  | March 31, 2018 (1) (2) |  | April 1, 2017 (1) (2)
Stock options and ESPP | 1.6 |  |  | 0.3 |  |  | 1.6 |  |  | 0.3 |
Restricted Stock Units | 6.8 |  |  | — |  |  | 7.5 |  |  | — |
Total potentially dilutive securities | 8.4 |  |  | 0.3 |  |  | 9.1 |  |  | 0.3 |
(1) The Company’s 0.625% Senior Convertible Notes due 2033 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $11.28 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 10. Debt” for more details. (2) The Company’s 1.00% Senior Convertible Notes due 2024 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $13.22 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 10. Debt” for more details.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration